Therapy Areas: Allergy
US FDA Grants IND, Approves Clinical Trial Protocol of Inhaled Ampion for COVID-19 Patients with Respiratory Distress
21 September 2020 - - US-based biopharmaceutical company Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) has been granted an Investigational New Drug from the US Food and Drug Administration, allowi...
CEBINA Touts Positive Findings on the Potency of Azelastine, a Widely Used Anti-Histamine, as Anti-COVID-19 Approach
18 September 2020 - - Austria-based biotechnology company CEBINA GmbH has released further positive results in its collaborative COVID-19 drug repurposing project, demonstrating that a common allergy ...
Interim Data Reported for COVID-19 Antibody in Phase 2 Clinical Trials
17 September 2020 - - Interim data from a Phase 2 clinical trial of LY-CoV555, the first antibody to emerge from Canada-based AbCellera's collaboration with US-based Eli Lilly and Company (NYSE: ...
Experimental COVID-19 Drug Shows Promise in Preliminary Cell Research
16 September 2020 - - An early study in human cells found that an antiviral drug candidate, US-based pharmaceutical company Pfizer Inc.'s (NYSE: PFE) PF-00835231, may be at least as potent as the...
Baricitinib in Combination with Remdesivir Reduces Time to Recovery in Hospitalized Patients with COVID-19 in NIAID-Sponsored ACTT-2 Trial
16 September 2020 - - US-based biopharmaceutical companies Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ: INCY) have received initial data emerging from the Adaptive COVID-19 Treatment Tri...
NYU Grossman School of Medicine and Pfizer's study shows effectiveness of PF-00835231 at blocking viral replication in COVID-19
16 September 2020 - NYU Grossman School of Medicine said on Tuesday that an early study in human cells found that Pfizer Inc's antiviral drug candidate PF-00835231 may be at least as potent as th...
Related Headlines

WorkCare Provides COVID-19 Diagnostic Saliva Test for Workplace and Home Use

Intravacc announces US NIH/NIAID agreement to develop Enterovirus D68 Vaccine

HDT BIO Receives NIH Contract to Advance Novel RNA/LION COVID-19 Vaccine Into Clinical Trials

Development of COVID-19 Vaccine AZD1222 Expands Into US Phase III Clinical Trial Across All Adult Age Groups

Sound Pharmaceuticals to test SPI-1005 in two Phase 2 studies as novel treatment for COVID-19

Aimmune Therapeutics to be acquired by Sociétés des Produits Nestlé SA in Q4 2020

US FDA Grants Emergency Use Authorization to Gilead's Investigational Antiviral Veklury (Remdesivir) for the Treatment of Patients With Moderate COVID-19

Moderna In Advanced Talks with European Commission to Supply Europe with 80 m Doses of mRNA Vaccine Against COVID-19

PathogenDx wins second NIH grant to develop accurate and faster COVID-19 testing

PathogenDx Awarded Second NIH Grant to Develop More Accurate and Faster COVID-19 Testing

Chrysalis BioTherapeutics Receives Additional Funding from the National Institutes of Health for COVID-19 Therapeutic Development

US government signs USD1.525bn deal with Moderna for 100 million doses of its COVID-19 vaccine

Gilead Submits New Drug Application to US Food and Drug Administration for Veklury for the Treatment of COVID-19

FDA Grants Inhaled Use IND for RLF-100 to Treat Patients with Moderate and Severe COVID-19 Aiming to Prevent Progression to Respiratory Failure

The National Institutes of Health's National Institute of Allergy and Infectious Diseases awards contract to SRI International